First, our study revealed that the Nampt inhibitor FK866 can induce ferroptosis in CRC; however, the anticancer effect of targeting NAD+ metabolism has been closely correlated with apoptosis and autophagy in other cancer types.[47, 48, 49] FK866 may induce distinct forms of cell death in various subtypes of tumor cells. Here, NAMPT is linked to cancer.